Clinical trial
Re-Evaluation of the Corvia Atrial Shunt Device in a Precision Medicine Trial to Determine Efficacy in Mildly Reduced or Preserved Ejection Fraction (EF) Heart Failure (Protocol #2201)
NCT05425459 is registered in ClinicalTrials.gov with Corvia Medical as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Re-Evaluation of the Corvia Atrial Shunt Device in a Precision Medicine Trial to Determine Efficacy in Mildly Reduced or Preserved Ejection Fraction (EF) Heart Failure (Protocol #2201)
- Lead sponsor
- Corvia Medical
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- November 17, 2022
- Completion date
- March 31, 2031
- Enrollment
- 750 (estimated)
- Sites
- 61
Conditions
As the registry lists them; a condition with its own page is linked.